Literature DB >> 3086569

Genetic control of serum neutralizing-antibody response to rabies vaccination and survival after a rabies challenge infection in mice.

J W Templeton, C Holmberg, T Garber, R M Sharp.   

Abstract

Quantitative differences in serum neutralizing-antibody (SNAb) responses to rabies vaccination and survival after a rabies challenge infection between two inbred mice strains, C3H/J and C57BL/6J, were shown to be under genetic control. A 99% confidence limit calculated from the SNAb response titers of 14 C57BL/6J mice resulted in an upper limit for the SNAb response titer of C57BL/6J mice at 50.63. A SNAb titer less than or equal to 50.63 in response to rabies vaccination was assigned the phenotype of hyporesponder, and a SNAb titer greater than 50.63 in response to rabies vaccination was assigned the phenotype of hyperresponder in this study. The hyper-SNAb response to rabies vaccination and the higher frequency of survival after rabies challenge infection behave as Mendelian dominant alleles in F1 hybrids (C3H/J X C57BL/6J) and backcross (BC) (F1 [C3H/J X C57BL/6J] X C57BL/6J) progeny. Both a relatively hyper-SNAb response and a higher frequency of vaccine-inducible survival phenotypes occur in C3H/J mice. On the other hand, both the relatively hypo-SNAb response and a lower frequency of vaccine-inducible survival phenotypes behave as Mendelian recessive alleles and occur in C57BL/6J mice. C3H/J mice are H-2 Kk, and C57BL/6J mice are H-2 Kb. All three phenotypic traits (H-2 type, SNAb response, and survival after rabies challenge infection) segregate as independent (unlinked) monogenic traits in BC progeny (F1 [C3H/J X C57BL/6J] X C57BL/6J). The genetically controlled survival trait is inducible by rabies vaccination, but SNAb response is not a parameter that measures successful vaccine induction of preexposure protection from a rabies challenge infection in the BC progeny. The essential role of vaccination in developing preexposure protection in genetically responsive mice is confirmed, but indicates that in vitro measurements other than SNAb titers need to be developed to identify mice that have failed to achieve preexposure protection by rabies vaccination. This study confirms Lodmell's findings (D. L. Lodmell and B. Chesebro, J. Virol. 50:359-362, 1984; D. L. Lodmell, J. Exp. Med. 157:451-460, 1983) that susceptibility to rabies infection is genetically controlled in some mice strains. Additionally, this study indicates that conventional rabies vaccination even with more potent vaccines may not induce protection from infection in some genetically susceptible individuals.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3086569      PMCID: PMC253043     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Trial of human diploid cell rabies vaccine in human volunteers.

Authors:  U Shah; G S Jaswal; H J Mansharamani; S A Plotkin; T J Wiktor
Journal:  Br Med J       Date:  1976-04-24

2.  Immunization schedules for the new human diploid cell vaccine against rabies.

Authors:  S A Plotkin; T J Wiktor; H Koprowski; E I Rosanoff; H Tint
Journal:  Am J Epidemiol       Date:  1976-01       Impact factor: 4.897

3.  The role of antibody in recovery from experimental rabies. I. Effect of depletion of B and T cells.

Authors:  A Miller; H C Morse; J Winkelstein; N Nathanson
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

4.  A rapid reproducible test for determining rabies neutralizing antibody.

Authors:  J S Smith; P A Yager; G M Baer
Journal:  Bull World Health Organ       Date:  1973-05       Impact factor: 9.408

5.  Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.

Authors:  K K Mittal; M R Mickey; D P Singal; P I Terasaki
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

Review 6.  Rabies vaccination.

Authors:  S A Plotkin; T Wiktor
Journal:  Annu Rev Med       Date:  1978       Impact factor: 13.739

7.  Murine resistance to street rabies virus: genetic analysis by testing second-backcross progeny and verification of allelic resistance genes in SJL/J and CBA/J mice.

Authors:  D L Lodmell; B Chesebro
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

8.  Effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine.

Authors:  R K Sikes; W F Cleary; H Koprowski; T J Wiktor; M M Kaplan
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

9.  Monoclonal antibodies against rabies virus produced by somatic cell hybridization: detection of antigenic variants.

Authors:  T J Wiktor; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

10.  Antibody response to a human diploid cell rabies vaccine.

Authors:  V J Cabasso; M B Dobkin; R E Roby; A H Hammar
Journal:  Appl Microbiol       Date:  1974-03
View more
  6 in total

1.  Polygenic control of antibody production and correlation with vaccine induced resistance to rabies virus in high and low antibody responder mice.

Authors:  M De Franco; S Massa; R C Vassão; M Siqueira; O A Sant'Anna
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 2.  Superantigen related to rabies.

Authors:  M Lafon; A Galelli
Journal:  Springer Semin Immunopathol       Date:  1996

3.  Cells with natural killer activity in human rabies.

Authors:  T Panpanich; T Hemachudha; S Piyasirisilp; S Manatsathit; H Wilde; P Phanuphak
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

4.  Intracerebral vaccination suppresses the spread of rabies virus in the mouse brain.

Authors:  Yuji Sunden; Shiori Yano; Sachiyo Ishida; Kenji Ochiai; Takashi Umemura
Journal:  Microbes Infect       Date:  2010-08-14       Impact factor: 2.700

5.  Onchocerca volvulus bivalent subunit vaccine induces protective immunity in genetically diverse collaborative cross recombinant inbred intercross mice.

Authors:  Nathan M Ryan; Jessica A Hess; Fernando Pardo-Manuel de Villena; Benjamin E Leiby; Ayako Shimada; Lei Yu; Amir Yarmahmoodi; Nikolai Petrovsky; Bin Zhan; Maria Elena Bottazzi; Benjamin L Makepeace; Sara Lustigman; David Abraham
Journal:  NPJ Vaccines       Date:  2021-01-26       Impact factor: 7.344

6.  Evidence of rabies virus exposure among humans in the Peruvian Amazon.

Authors:  Amy T Gilbert; Brett W Petersen; Sergio Recuenco; Michael Niezgoda; Jorge Gómez; V Alberto Laguna-Torres; Charles Rupprecht
Journal:  Am J Trop Med Hyg       Date:  2012-08       Impact factor: 2.345

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.